Delivery Order SPE2DB22D1106-SPE2DB25FERG7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 per unit, with a ceiling value of $12,891.33. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-competitive delivery order, valued at $13,063.67 with firm fixed pricing, represents a pharmaceutical procurement under the agency's medical supply chain operations. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and...
- The Defense Logistics Agency awarded a $7,484.21 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 17, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete openly for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $13,626.03 and an ultimate completion date of October 17, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitive award, valued at $10,669.37 with firm fixed pricing, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of July 24, 2025. No...
- The Defense Logistics Agency awarded a $8,416.97 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30. This is a firm fixed price, competitively awarded contract with a completion date of September 22, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The order will be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $34,386.90 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed price, competitively awarded delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a ceiling value of $17,848.57. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a $20,861.79 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal pharmaceutical procurement needs. The work is scheduled for completion by August 1, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,658.42 to supply Descovy 200-25 mg tablets in quantities of 30, with performance in Conshohocken, Pennsylvania. The award, issued on August 18, 2025, represents a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FERG7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a ceiling value of $6,140.30 and a completion date of June 3, 2025. This competitive award, which utilized no set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor serving federal healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's federal contract portfolio demonstrates extensive experience supplying brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award reflects the company's continued role as a critical vendor within the federal medical supply chain and the DLA's reliance on established prime vendors for rapid pharmaceutical procurement to support military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 6/2/25 |